Cision
By slangadmin
Debut Biotech Raises $22.6M Series A to Commercialize High-Value Ingredients from Proprietary Cell-Free Biomanufacturing Platform
Contact us.
Sign up for news and views that make an impact.
By slangadmin
Debut Biotech Raises $22.6M Series A to Commercialize High-Value Ingredients from Proprietary Cell-Free Biomanufacturing Platform
Sign up for news and views that make an impact.